Eligibility and cost for icosapent ethyl based on the reduce-it trial: Insight from the veterans affairs healthcare system

Xiaoming Jia, Julia M. Akeroyd, Khurram Nasir, Vijay Nambi, Christie M. Ballantyne, Laura A. Petersen, Salim S. Virani

Research output: Contribution to journalLetterpeer-review

8 Scopus citations
Original languageEnglish (US)
Pages (from-to)1341-1343
Number of pages3
JournalCirculation
Volume139
Issue number10
DOIs
StatePublished - Mar 5 2019

Keywords

  • icosapent ethyl

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine
  • Physiology (medical)

Cite this